Meningococcal Clinical Trials

1 recruiting

Meningococcal Trials at a Glance

8 actively recruiting trials for meningococcal are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Seoul, Ghent, and Incheon. Lead sponsors running meningococcal studies include Emory University, EyeGene Inc., and Association Clinique Thérapeutique Infantile du val de Marne.

Browse meningococcal trials by phase

Treatments under study

About Meningococcal Clinical Trials

Looking for clinical trials for Meningococcal? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Meningococcal trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Meningococcal clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

National Bacterial Meningitis Study in Children and Newborns

MeningitisChildren, OnlyNeonatal Infection+5 more
Association Clinique Thérapeutique Infantile du val de Marne10,000 enrolled1 locationNCT04664569
Recruiting
Phase 3

Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

Healthy VolunteersMeningococcal Infection
Sanofi1,602 enrolled2 locationsNCT07135986
Recruiting
Phase 4

Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

VaccinationTransgender PersonsMeningococcal Meningitis, Serogroup B+1 more
University Ghent250 enrolled1 locationNCT06832514
Recruiting
Phase 3

Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Drug

InfectionsMeningococcal
NPO Petrovax240 enrolled17 locationsNCT06834100
Recruiting
Phase 2Phase 3

Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old

Meningococcal Infections
EyeGene Inc.1,123 enrolled1 locationNCT07204457
Recruiting

Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)

Meningococcal Infection
Sanofi Pasteur, a Sanofi Company50 enrolled1 locationNCT04843111
Recruiting
Phase 2

Azithromycin for Meningococcal Carriage

Meningococcal Infections
Emory University1,120 enrolled1 locationNCT06618534
Recruiting
Phase 4

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Meningitis, Meningococcal
GlaxoSmithKline50 enrolled10 locationsNCT06113198